2022
DOI: 10.17352/ojor.000044
|View full text |Cite
|
Sign up to set email alerts
|

Chondrosarcoma of the right iliopubic branch incidentally discovered: About a case

Abstract: Chondrosarcoma is the most common primary malignant bone tumor after myeloma and osteosarcoma, ranking third. It may be in second place in terms of frequency after osteosarcoma if we consider myeloma as a tumor of bone marrow cells rather than a bone tumor because it is a hematopoietic derivation [1].

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(7 citation statements)
references
References 8 publications
0
0
0
Order By: Relevance
“…Chondrosarcoma of the pelvis poses a severe challenge in terms of treatment for its resistance to both radiotherapy and chemotherapy. Consequently, the primary mode of management predominantly involves surgical intervention [ 3 ]. However, the intricate anatomical nature of the pelvis presents formidable obstacles, as it lacks significant anatomical barriers to constrain tumor expansion.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Chondrosarcoma of the pelvis poses a severe challenge in terms of treatment for its resistance to both radiotherapy and chemotherapy. Consequently, the primary mode of management predominantly involves surgical intervention [ 3 ]. However, the intricate anatomical nature of the pelvis presents formidable obstacles, as it lacks significant anatomical barriers to constrain tumor expansion.…”
Section: Discussionmentioning
confidence: 99%
“…Chondrosarcomas encompasses neoplasms derived from mesenchymal lineage cells and are characterized by the production of a cartilaginous matrix that may arise de novo or develop as a sequel to pre-existing benign cartilaginous neoplasms [ 1 , 2 ]. While its prevalence is eclipsed by myeloma and osteosarcoma, it ranks as the third most common primary malignant bone tumor [ [2] , [3] , [4] ]. Its incidence is notably variable, with European rates approximating 1–4 cases per 100,000 individuals [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations